These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [An increase of serum lactic acid by monoamine oxidase inhibitor]. GEY KF; PLETSCHER A Helv Physiol Pharmacol Acta; 1960 May; 56():70-3. PubMed ID: 13858656 [No Abstract] [Full Text] [Related]
26. [The action of some inhibitors of monoamine oxidase on experimental rat paw edema]. CREMA A; BERTE F Boll Soc Ital Biol Sper; 1960 Oct; 36():1069-73. PubMed ID: 13696364 [No Abstract] [Full Text] [Related]
27. [First results with a new substance with monoamine oxidase antagonist action in the treatment of infantile anorexia]. CAMMARELLA C; POZZUOLI M Minerva Med; 1959 Dec; 50():4453-4. PubMed ID: 13807183 [No Abstract] [Full Text] [Related]
28. [Action of monoamine oxidase inhibitors on the cerebral electrical activity of the rabbit]. SAVOLDI F; MAGGI GC; NOLI S Boll Soc Ital Biol Sper; 1960 Dec; 36():1423-5. PubMed ID: 13746930 [No Abstract] [Full Text] [Related]
29. New inhibitor of monoamine oxidase. TAYLOR JD; WYKES AA; GLADISH YC; MARTIN WB Nature; 1960 Sep; 187():941-2. PubMed ID: 13775618 [No Abstract] [Full Text] [Related]
30. [Amine oxidases]. Levy L Therapie; 1968; 23(5):1003-36. PubMed ID: 4883547 [No Abstract] [Full Text] [Related]
31. Lack of relationship between inhibition of monoamine oxidase and potentiation of hexobarbital hypnosis. LAROCHE MJ; BRODIE BB J Pharmacol Exp Ther; 1960 Oct; 130():134-7. PubMed ID: 13759147 [No Abstract] [Full Text] [Related]
32. The action of carbon disulphide on cerebral monoamine oxidase. MAGISTRETTI M; PEIRONE E Med Lav; 1961 Jan; 52():1-10. PubMed ID: 13765255 [No Abstract] [Full Text] [Related]
33. Monoamine oxidases: versatility of catalytic properties and possible biological functions. Gorkin VZ Adv Pharmacol Chemother; 1973; 11():1-50. PubMed ID: 4201892 [No Abstract] [Full Text] [Related]
34. [Inhibitors of monoamine oxidases: pharmacological properties and clinical effects of beta-phenylisopropylhydrazine and of nialamide]. GRATTAROLA FR; ROVERA GG Riv Patol Nerv Ment; 1960; 81():303-18. PubMed ID: 13707969 [No Abstract] [Full Text] [Related]
35. [On monoamine-oxidase inhibitors (iproniazid and derivatives)]. PERRAULT M; DRY J Prog Med (Paris); 1961 Jan; 89():9-12. PubMed ID: 13734495 [No Abstract] [Full Text] [Related]
36. [The pharmacology of monoamine oxidase inhibitors]. IISALO E Duodecim; 1960; 76():585-95. PubMed ID: 13717436 [No Abstract] [Full Text] [Related]
38. Current trends in the use of monoamine oxidase inhibitors in depression. PRANGE AJ N C Med J; 1960 Dec; 21():546-7. PubMed ID: 13737718 [No Abstract] [Full Text] [Related]
39. [On the use of monoamine oxidase inhibitors in internal medicine. Experimental bases and clinical results]. SCHMID E; SCHEIFF ARTH F Arzneimittelforschung; 1961 Jul; 11():612-6. PubMed ID: 13747891 [No Abstract] [Full Text] [Related]